BIOSIMILARS

Molecule (Brand) Marketed Indications Development Pre-Clinical Clinical Launch
Teriparatide (Forteo/Forsteo) Osteoporosis
Denosumab (Prolia/Xgeva) Osteoporosis, Cancer-Related Indications
Romiplostim (N-Plate) Chronic Idiopathic Thrombocytopenic Purpura
Cetuximab (Erbitux) Metastatic Colorectal Cancer, Head &
Neck Cancer
Adalimumab (Humira) Rheumatoid Arthritis, Ulcerative Colitis,
Crohn's Disease, etc.
Bevacizumab (Avastin) Metastatic Colorectal Cancer, Non-Small
Cell Lung Cancer
Ranibizumab (Lucentis) Wet Age-Related Macular Degeneration
Liraglutide (Victoza) Type 2 Diabetes
Tocilizumab (Actemra) Rheumatoid Arthritis
Pertuzumab (Perjeta) Cancer-Related Indications